As an injection (Intramuscular, IM, or Subcutaneous, SC), it is highly effective for patients who cannot properly absorb Vitamin B12 through the digestive system due to underlying conditions like pernicious anThere are no known significant interactions between injectable B12 and food, as the injection bypasses the entire digestive system
Improvement of feed conversion
Injectable GHK-Cu reaches tissue concentrations roughly 1020 times higher than equivalent topical application
LY3437943 (Retatrutide): discovery to clinical proof of concept (triple GLP-1/GIP/glucagon agonist, preclinical mechanism) Nature Reviews Endocrinology (2024) Multi-receptor agonists for metabolic disease (mechanism of GLP-1/GIP/glucagon co-activation) Diabetes Care (2024) Incretin-based therapies: GLP-1, GIP, and glucagon receptor pharmacology (metabolic pathways, energy expenditure) NEJM (2023) Supplementary Material Jastreboff et al
Narsinh KH, Hui F, Saloner D, et al
Think of it as a repair signal that may be layered on top of standard care, not a replacement